StreetInsider.com News Articles

Form 8-K/A enGene Therapeutics Inc. For: Jun 16

Thu, 18 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260618/26665973.html

Form 8-K/A enGene Therapeutics Inc. For: Jun 16

Thu, 18 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260618/26665973.html

Morgan Stanley Downgrades Engene Holdings Inc. (ENGN) to Underweight

Thu, 18 Jun 2026 02:37:29 -0400

Morgan Stanley analyst Judah Frommer downgraded Engene Holdings Inc. (NASDAQ: ENGN) from Equalweight to Underweight.

The analyst comments: “We have engaged with both KOLs and investors following the interim update from the LEGEND study (see here), in order to better gauge the role that detalimogene might play in treating BCG-unresponsive NMIBC with CIS in light of the recent data. Despite an evolving treatment landscape and the potential for detalimogene's efficacy to improve numerically with the 2H26 update, we have noted reduced confidence from physicians that LEGEND would support significant adoption of detalimogene and more of a 'show me' approach to potential

Morgan Stanley Downgrades Engene Holdings Inc. (ENGN) to Underweight

Thu, 18 Jun 2026 02:37:29 -0400

Morgan Stanley analyst Judah Frommer downgraded Engene Holdings Inc. (NASDAQ: ENGN) from Equalweight to Underweight.

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Astley-Sparke Philip

Wed, 17 Jun 2026 17:44:00 -0400

si-local-file:///var/storage/secattach/20260617/26661107.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Astley-Sparke Philip

Wed, 17 Jun 2026 17:44:00 -0400

si-local-file:///var/storage/secattach/20260617/26661107.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: BRUNK GERALD A

Wed, 17 Jun 2026 17:43:00 -0400

si-local-file:///var/storage/secattach/20260617/26661101.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: BRUNK GERALD A

Wed, 17 Jun 2026 17:43:00 -0400

si-local-file:///var/storage/secattach/20260617/26661101.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Glickman Richard M

Wed, 17 Jun 2026 17:42:00 -0400

si-local-file:///var/storage/secattach/20260617/26661099.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Glickman Richard M

Wed, 17 Jun 2026 17:42:00 -0400

si-local-file:///var/storage/secattach/20260617/26661099.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Grossman William

Wed, 17 Jun 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260617/26661093.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Grossman William

Wed, 17 Jun 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260617/26661093.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: HASTINGS PAUL J

Wed, 17 Jun 2026 17:39:00 -0400

si-local-file:///var/storage/secattach/20260617/26661087.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: HASTINGS PAUL J

Wed, 17 Jun 2026 17:39:00 -0400

si-local-file:///var/storage/secattach/20260617/26661087.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Heffernan Michael Thomas

Wed, 17 Jun 2026 17:38:00 -0400

si-local-file:///var/storage/secattach/20260617/26661082.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Heffernan Michael Thomas

Wed, 17 Jun 2026 17:38:00 -0400

si-local-file:///var/storage/secattach/20260617/26661082.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Joustra Wouter

Wed, 17 Jun 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260617/26661075.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Joustra Wouter

Wed, 17 Jun 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260617/26661075.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Zoth Lota S.

Wed, 17 Jun 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260617/26661078.html

Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Zoth Lota S.

Wed, 17 Jun 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260617/26661078.html

Engene Holdings Inc. (ENGN) PT Lowered to $4 at H.C. Wainwright

Tue, 16 Jun 2026 06:09:27 -0400

H.C. Wainwright analyst Andres Maldonado lowered the price target on Engene Holdings Inc. (NASDAQ: ENGN) to $4.00 (from $6.00) while maintaining a Buy rating.

The analyst comments "What’s new? Yesterday, enGene released 2Q26 earnings alongside clinical updates on patient enrollment for the new LEGEND cohort evaluating detalimogene with polidocanol, a surfactant bladder rinse designed to test whether a brief pre-rinse can improve the consistency, distribution, and depth of urothelial transfection. The new cohort aims to evaluate the added benefit of a pre-rinse in improving the consistency of patient responses to therapy, following the interim Cohort 1 LEGEND update, which fell short

Engene Holdings Inc. (ENGN) PT Lowered to $4 at H.C. Wainwright

Tue, 16 Jun 2026 06:09:27 -0400

H.C. Wainwright analyst Andres Maldonado lowered the price target on Engene Holdings Inc. (NASDAQ: ENGN) to $4.00 (from $6.00) while maintaining a Buy rating.

Form 10-Q enGene Therapeutics Inc. For: Apr 30

Mon, 15 Jun 2026 09:17:00 -0400

si-local-file:///var/storage/secattach/20260615/26645183.html

Form 10-Q enGene Therapeutics Inc. For: Apr 30

Mon, 15 Jun 2026 09:17:00 -0400

si-local-file:///var/storage/secattach/20260615/26645183.html

Form 8-K enGene Therapeutics Inc. For: Jun 13

Mon, 15 Jun 2026 09:15:00 -0400

si-local-file:///var/storage/secattach/20260615/26645163.html